Pluri's 3D technology enables the cultivation of plant cells in bioreactors to develop sustainable, disease-free plant materials for a variety of sectors, from sustainable agriculture to medicine.

According to the company, about a fifth of the 50,000 medicinal plants currently in use are on the endangered species list, and climate change and limited access to fresh water are causing temperatures to drop in crops such as coffee and cacao. Sensitive crops are being threatened.

Yaky Yanay, CEO and President of Pluri commented: “PluriAgtech’s patented technology can be used in a wide range of plant cell products, including food and beverages, pharmaceuticals, and raw materials.

“This important patent solidifies our leadership in cell proliferation technology and is consistent with our strategic vision to industrially scale up the production of cell-based products, potentially opening up a wide range of market opportunities. .”

cell-based coffee
© Pururi

Coffee and other phytochemicals

PluriAgtech leverages Pluri's 3D cell expansion technology to produce cell-based coffee.

As Pluri explains, coffee consumption has increased by 60% over the past 30 years. But the $130 billion and rapidly growing coffee industry is facing a global warming crisis that threatens to reduce the amount of suitable growing land by 50% by 2050.

However, Pururi claims that its plant cell culture technology allows it to produce high-quality coffee using 98% less water and 95% less cultivated area, thus preventing deforestation and making it a viable solution to the coffee crisis. are doing.

Diagram showing how Pluri takes samples from coffee plants and grows cells in a bioreactor.
© Pururi

Similar to cultured meat, culturing plant cells relies on cells and their ability to grow in bioreactors under controlled settings, as well as raw materials that support cell replication and growth. In the case of coffee, cells are grown until they reach the desired biomass, then collected, dried, and roasted to form the final product.

Pluri's cell culture technology is valuable because it enables the development of a wide range of phytochemicals without relying on crops, relieving some of the pressure that agriculture places on land, water and biodiversity.

With more than 140 active and granted patents, Pluri believes its IP portfolio underscores its role as a pioneer in the agtech industry and provides the company with a competitive advantage in innovation.

Mr. Yanai further added, “We see many opportunities in the agritech space, and Pluli is committed to providing sustainable solutions to humanity's greatest challenges through our own products and in collaboration with potential partners.” We are at the forefront of providing possible solutions,” he added.



Source link